Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7235 p189
8 February 2003

This page
Reprint
Photocopy

   

PDF* 90K

Letters

  OFT report
  Locum pharmacy
  Hospital pharmacy
  Dispensing
  Heart disease
  The Profession
  The Society
  The Journal


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Heart disease

What about fish consumption?

From Mr H. A. Tyrrell, MRPharmS

The recent continuing professional development article (PDF 75K) on primary prevention of heart disease (PJ, 18 January, pp86–88) provided a useful overview of the subject. However I was puzzled at the absence of comment regarding the value of including fish in the diet. It is well established that regular consumption of fish can significantly reduce cardiovascular disease and mortality, probably due to the presence of omega-3 fatty acids and their effects in lowering triglycerides and risk of thromboses and arrhythmias.

Both the British Heart Foundation and American Heart Association advocate the regular inclusion of fish in the diet, although current United Kingdom advice from the Food Standards Agency is to limit this to two servings per week (including one of oily fish) owing to concerns over possible contamination of fish stock by industrial pollutants.

It would also be interesting to have the authors comments on the value or otherwise of incorporating soy protein in the diet as a means of reducing cholesterol levels.

H. Tyrrell
Horsham, West Sussex

 

HELEN WILLIAMS, Duncan McRobbie and Rhian Davies reply:

We thank your correspondent for his interest in our article, which focused primarily on areas in which drug therapy might be employed, alongside lifestyle change, to address cardiovascular risk. Coronary heart disease is a multi-faceted disease and primary prevention should always start with lifestyle adjustment, which would include a healthy diet.

The most recent summary of primary prevention strategies from the AHA advocates consumption of a variety of fruit, vegetables, grains, low-fat or non-fat dairy products, fish, legumes, poultry and lean meats and refers specifically to the role of unsaturated fatty acids from fish, vegetables, legumes and nuts.1 Epidemiological studies and clinical trials have established the role of omega-3 fatty acids in reducing the incidence of cardiovascular disease, although the ideal intake has not yet been clearly established. As your correspondent pointed out the current recommendations are to limit this to two servings of fatty fish per week.2 Soy protein is a rich source of omega-3 oils, and there are data to indicate that soy protein may have a role in improving the lipid profile. Although this may support the inclusion of soy protein within the diet, it does not match the reductions possible where statins are appropriately employed.3

When considering the data to support the inclusion of individual foods within the diet, advice should be tailored to the individual patient. It is well recognised that lifestyle modification is difficult and the recommendations made must be realistic and achievable.4


References

1. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation 2002;106:388–91.

2. Kris-Etherton PM, Harris WH, Appel LJ for the Nutrition Committee. Fish consumption, fish oil, omega-3-fatty acids and cardiovascular disease. Circulation 2002:106:2747– 57.

4. Erdman JW for the AHA Nutrition Committee. Soy protein and cardiovascular disease. Circulation 2000; 102:2555–9.

4. Kottke TE. What is the Optimal diet for heart health? BMJ USA 2001; 1:222–3.

Send your letter to The Editor

Previous Topic (Dispensing)
Next Topic (The Profession)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal